Brainsway Ltd Revenue Growth Rates (BWAY), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Brainsway Ltd   (NASDAQ: BWAY)
 

BWAY's Revenue Growth by Quarter and Year

Brainsway Ltd 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BWAY Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter December 52.23
3rd Quarter September 0.00
2nd Quarter June 0.00
1st Quarter March 0.00
FY 52.23

BWAYs Annual Revenue
Brainsway Ltd 's Revenue in the fiscal year 2025 $ 52.23 millions
Brainsway Ltd 's Revenue in the fiscal year 2024 $ 41.02 millions
Brainsway Ltd 's Revenue in the fiscal year 2023 $ 31.79 millions
Brainsway Ltd 's Revenue in the fiscal year 2022 $ 27.18 millions
Brainsway Ltd 's Revenue in the fiscal year 2021 $ 29.66 millions




BWAY Revenue fourth quarter 2025 Y/Y Growth Comment
Brainsway Ltd achieved in the fourth quarter 2025, above Company average Revenue growth of 27.32% year on year, to $ 52.23 millions.

Looking into fourth quarter 2025 results within Medical Equipment & Supplies industry 129 other companies have achieved higher Revenue growth. While Brainsway Ltd ' s Revenue rise of 27.32% ranks overall at the positon no. 2750 in the fourth quarter 2025.


BWAY Revenue ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter December 27.32 % 29.03 % 16.96 % -8.36 %
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   27.32 % 29.03 % 16.96 % -

Financial Statements
Brainsway Ltd 's fourth quarter 2025 Revenue $ 52.23 millions BWAY's Income Statement
Brainsway Ltd 's fourth quarter 2024 Revenue $ 41.02 millions Quarterly BWAY's Income Statement


BWAY Revenue (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY (Year on Year)   27.32 % 29.03 % 16.96 % -


Back to BWAY Growth rate Comparisons >> Back to BWAY Growth rate Comparisons >>


Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #130
Healthcare Sector #375
Overall #2750

Revenue Y/Y Growth Statistics
High Average Low
16.96 % 4.3 % -8.36 %
(Dec 31 2023)   (Dec 31 2022)
Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #130
Healthcare Sector #375
Overall #2750
Revenue Y/Y Growth Statistics
High Average Low
16.96 % 4.3 % -8.36 %
(Dec 31 2023)   (Dec 31 2022)

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Brainsway Ltd 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BWAY's IV. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BWAY's IV. Quarter Q/Q Revenue Comment


Brainsway Ltd 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Dec 31 2024)		 12 Months Ending
(Dec 31 2023)		 12 Months Ending
(Dec 31 2022)		 12 Months Ending
(Dec 31 2021)
Cumulative Revenue 12 Months Ending $ 52.23 $ 41.02 $ 31.79 $ 27.18 $ 29.66
Y / Y Revenue Growth (TTM) 27.33 % 29.04 % 16.96 % -8.36 % 34.46 %
Year on Year Revenue Growth Overall Ranking # 2750 # 2959 # 2900 # 0 # 0
Seqeuential Revenue Change (TTM) 27.33 % 29.04 % 16.96 % -8.36 % 34.46 %
Seq. Revenue Growth (TTM) Overall Ranking # 2750 # 2959 # 2900 # 0 # 0


Cumulative Revenue growth Comment
Assuming the Brainsway Ltd 's fiscal year would have ended in Dec 31 2025, Brainsway Ltd would have reprted above average annual Revenue rise of 27.33% year on year, of $ 52 millions.
This marks a slow-down of the companys growth trends and from the 29.04% improvement in Dec 31 2024.

In the Healthcare sector 374 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2750, from total ranking in previous quarter at 2959.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 130
Healthcare Sector # 375
Overall # 2750

Revenue TTM Y/Y Growth Statistics
High Average Low
16.96 %
 4.3 %
-8.36 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 130
Sector # 375
S&P 500 # 2750
Cumulative Revenue growth Comment
Assuming the Brainsway Ltd 's fiscal year would have ended in Dec 31 2025, Brainsway Ltd would have reprted above average annual Revenue rise of 27.33% year on year, of $ 52 millions.
This marks a slow-down of the companys growth trends and from the 29.04% improvement in Dec 31 2024.

In the Healthcare sector 374 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2750, from total ranking in previous quarter at 2959.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 130
Healthcare Sector # 375
Overall # 2750

Revenue TTM Y/Y Growth Statistics
High Average Low
16.96 %
4.3 %
-8.36 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 130
Sector # 375
S&P 500 # 2750




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
BWAY's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue improvement for the quarter ending Dec 31 2025 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2025
Intelligent Bio Solutions Inc 47.62%$ 47.619 millions
Gossamer Bio Inc 47.13%$ 47.127 millions
Electrocore Inc 46.11%$ 46.111 millions
Mannkind Corporation45.82%$ 45.820 millions
Hologic Inc44.84%$ 44.836 millions
Ensysce Biosciences Inc 44.39%$ 44.389 millions
Profound Medical Corp 43.13%$ 43.127 millions
Regenxbio Inc 43.00%$ 43.005 millions
Xeris Biopharma Holdings Inc 42.78%$ 42.776 millions
Eli Lilly And Company42.56%$ 42.557 millions
Edwards Lifesciences Corporation42.48%$ 42.484 millions
Rani Therapeutics Holdings Inc 42.12%$ 42.121 millions
Establishment Labs Holdings Inc 41.85%$ 41.854 millions
The Oncology Institute Inc 41.58%$ 41.579 millions
Cytosorbents Corporation41.55%$ 41.553 millions
Vystar Corporation41.19%$ 41.186 millions
Prelude Therapeutics Inc41.00%$ 41.000 millions
Biodesix Inc 40.76%$ 40.756 millions
Ligand Pharmaceuticals Incorporated40.01%$ 40.008 millions
Femasys Inc 39.84%$ 39.844 millions
Natera Inc 39.79%$ 39.793 millions
Guardant Health Inc 39.37%$ 39.369 millions
Innovative Eyewear Inc 38.96%$ 38.964 millions
Ceribell Inc 38.36%$ 38.357 millions
Gsk Plc37.35%$ 37.347 millions
Rapid Micro Biosystems Inc 37.28%$ 37.284 millions
Nexgel Inc 36.92%$ 36.918 millions
Rhythm Pharmaceuticals Inc 36.87%$ 36.871 millions
Adc Therapeutics Sa36.36%$ 36.357 millions
Logicmark Inc36.29%$ 36.290 millions


About Brainsway Ltd Revenue Growth Rates (BWAY), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Brainsway Ltd (CIK 1505065).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001171843-26-002568
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Brainsway Ltd ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.